ATPW
NNVC icon

Ashton Thomas Private Wealth’s NanoViricides NNVC Stock Holding History

Ashton Thomas Private Wealth’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-58
Closed -$100 – 1401
2024
Q2 		$100 Buy
+58
New +$103 ﹤0.01% 1915

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ashton Thomas Private Wealth's NNVC Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of NanoViricides (NNVC) in Q3 2024, closing a stake of 58 shares — an estimated $100 sold.

Ashton Thomas Private Wealth first reported a position in NNVC in Q2 2024 and held it in 1 quarter. The position peaked at $100 in Q2 2024. 32 funds tracked by Wall St. Rank hold NNVC as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining NanoViricides position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 58 NanoViricides shares in Q3 2024, an estimated $100.
  • Ashton Thomas Private Wealth first reported a position in NanoViricides in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's NanoViricides position peaked at $100 in Q2 2024.
  • 32 funds tracked by Wall St. Rank held NanoViricides as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.